Aurora Cannabis and Willow Biosciences have completed a confidential settlement resolving the ongoing patent litigation between the two parties in Canada. Aurora commenced a patent infringement action in July 2021, alleging that Willow’s biosynthetic process for synthesizing cannabinoids infringed Aurora’s exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACB:
- Rising High: Exclusive talk with cannabis lender FundCanna
- Rising High: Exclusive talk with financial services firm Safe Harbor Financial
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Rising High: Exclusive talk with medical cannabis company Clever Leaves
- Aurora Cannabis (NASDAQ:ACB) Rises on Approval to Transfer Listing